Together, these results suggest that the presence of the nucleotide A in the position -178 of the promoter region of NFE2L2 is associated with cirrhotic liver disease, since both ALD and HCV samples preferentially showed this polymorphism. This evidence concerns the gene NFE2L2 and liver disorder.